Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral versus vaginal progesterone for treatment of endometrial hyperplasia
IRCT20140820018866N8Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of progesterone in endometrial hyperplasia (EH) (2 arms), sponsored by Tehran University of Medical Sciences. Started Nov 2019; status: completed.
02
Drugs
progesterone
03
Conditions
endometrial hyperplasia (EH)
Beyond the preview
Go deeper on IRCT20140820018866N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140820018866N8.